Supply chain risk is not uniform across industries. A pharmaceutical company’s critical dependencies look nothing like a semiconductor company’s, and the disclosure language that signals real exposure versus boilerplate varies by sector. This analysis covers five sectors with distinct supply chain risk profiles in 2026 and explains what to look for in their SEC filings.

Semiconductors: Geographic Concentration as Systemic Risk

The semiconductor industry’s supply chain risk is unusual because geographic concentration exists at every tier simultaneously. Advanced logic chips are fabricated predominantly in Taiwan (TSMC) and South Korea (Samsung LSI). Advanced packaging is concentrated in Taiwan (TSMC CoWoS, ASE Group) and China (JCET, Tongfu Microelectronics). DRAM is concentrated in South Korea (Samsung, SK Hynix) and the United States (Micron). NAND flash is concentrated in Japan (Kioxia), South Korea (Samsung, SK Hynix), and the United States (Western Digital/Kioxia JV, Micron).

The implication: a supply disruption affecting Taiwan would simultaneously impact foundry capacity, advanced packaging, and substrate availability for the entire global semiconductor industry. There is no near-term geographic alternative for TSMC’s advanced node capacity.

What to look for in 10-K filings from semiconductor companies:

  • Risk factors that name Taiwan, South Korea, or China specifically (not just “geopolitical risk”)
  • Item 1 disclosures of “single source” or “limited number of foundry partners”
  • Purchase commitment footnotes showing multi-year wafer agreements — these indicate both concentration and the company’s view of supply security
  • Export control risk factors: U.S.-China semiconductor restrictions affect companies on both the selling and buying side

Cross-sector exposure: Semiconductor supply chain risk propagates downstream. A foundry disruption affects not only chip designers but also any company whose products contain custom silicon — cloud hyperscalers, automotive OEMs, defense contractors, medical device manufacturers. ChainSifter maps these second-order relationships by extracting semiconductor dependency disclosures from non-semiconductor company 10-Ks.

Aerospace and Defense: Long Lead Times and Single-Source Certification

Aerospace supply chains are distinguished by extreme lead times and regulatory certification requirements that create structural single-source dependencies. An aerospace fastener qualified for a specific airframe program may only be certified from one supplier — not because other suppliers couldn’t manufacture it, but because the FAA qualification process takes 18–24 months and no one has gone through it for that specific application.

This creates a category of supply chain risk that isn’t about capacity or geography — it’s about regulatory lock-in. A supplier that fails financially while holding the sole FAA qualification for a critical component can ground production at a major airframer. Spirit AeroSystems’ 2024 financial difficulties illustrated this directly: as the sole fuselage supplier for Boeing’s 737 MAX, Spirit’s problems were inseparable from Boeing’s production rate issues.

What to look for in 10-K filings from aerospace companies:

  • Risk factors that mention “long-lead items,” “sole-source suppliers,” or “supplier financial stability”
  • References to specific aircraft programs creating concentration — revenue from a single program that represents a large percentage of revenue creates both customer concentration and supplier concentration
  • Inventory disclosures: aerospace companies often carry significant raw material and WIP inventory as a buffer against long-lead items; unusual inventory builds can signal supply constraint anticipation

Pharmaceuticals: API Concentration and Chinese Precursor Dependency

Pharmaceutical supply chains have a specific and well-documented vulnerability: active pharmaceutical ingredient (API) manufacturing is heavily concentrated in China and India. An estimated 80–90% of API manufacturing capacity for many generic drugs is located in these two countries. For branded pharmaceuticals, the API concentration risk is similar — the underlying chemical synthesis for many molecules was offshored decades ago and has not been repatriated.

The FDA’s drug shortage tracking database is the downstream evidence of this risk: shortages often trace back to API manufacturing disruption at a single facility in Hyderabad or Wuhan. FDA inspection findings, import alerts on specific facilities, and CGMP violations at API manufacturers are supply chain signals that precede drug shortages by months.

What to look for in pharmaceutical 10-K filings:

  • API sourcing disclosures: some pharma companies disclose geographic API concentration, particularly after regulatory pressure following COVID-era shortages
  • Manufacturing facility disclosures: whether the company owns its own API manufacturing or is entirely contract-dependent
  • CMO (contract manufacturing organization) dependency: language about “limited number of manufacturing partners” or “single-source API suppliers”
  • FDA warning letters or import alerts affecting named facilities — these appear in 10-K Risk Factors after issuance

Electric Vehicles: Battery Materials as the Binding Constraint

EV supply chains in 2026 are fundamentally constrained by battery materials — lithium, cobalt, nickel, and manganese — and battery cell manufacturing capacity. The geographic concentration of battery cell manufacturing in China (Contemporary Amperex Technology Co., Limited, BYD, CATL subsidiaries) and South Korea (LG Energy Solution, Samsung SDI, SK On) means that EV supply chains have inherited the geographic concentration risks of the broader battery industry.

Lithium processing is even more concentrated: the Atacama triangle (Chile, Bolivia, Argentina) for brine lithium, and Australia and China for hard-rock spodumene. Chinese battery manufacturers have secured upstream lithium supply through direct ownership of South American and African mining assets — giving them an integrated position that Western EV OEMs are attempting to replicate but haven’t yet matched.

What to look for in EV company 10-K filings:

  • Battery supply agreements: disclosed cell supply contracts with CATL, LG, Panasonic, or Samsung SDI indicate single-source or multi-source strategies
  • Raw material purchase commitments: long-term lithium or nickel contracts often appear in purchase commitment footnotes
  • IRA (Inflation Reduction Act) compliance risk: EV companies increasingly disclose supply chain compliance with IRA battery sourcing requirements as a financial risk
  • Gigafactory ramp disclosure: companies building their own battery manufacturing disclose capacity, ramp timeline, and supply chain for cell components

Consumer Electronics: The Everything Problem

Consumer electronics supply chains combine the geographic concentration problems of semiconductors, the contract manufacturing dependencies of Apple’s model, and the commodity exposure of battery materials — all in products with compressed 12–18 month product cycles that leave little time to qualify alternative sources.

A consumer electronics company launching a new device in Q4 has typically locked its component suppliers 12–18 months earlier. If a key supplier encounters a yield problem, natural disaster, or geopolitical disruption in the months before launch, the option to qualify an alternative in time is limited. This time pressure is why 10-K Risk Factors from consumer electronics companies consistently flag “limited or single-source suppliers” as a risk — not because the company hasn’t tried to diversify, but because the product cycle economics make diversification structurally difficult.

The ChainSifter database covers supply chain relationships across all five sectors described here, extracted from SEC filing text and cross-referenced across the full public company corpus. Each relationship has a primary filing citation — you can see exactly where in which filing the relationship was disclosed.